Scientists at OMRF think they have solved a riddle that has puzzled researchers since the 1970s. For more than three decades, researchers have debated whether two types of pathogen-fighting cells—known as B1 and B2 cells—come from the same source. At long last, OMRF scientists appear to have found an answer. That work could have important […]
scientist-news
Harley named to the Association of American Physicians
Oklahoma Medical Research Foundation scientist John Harley, M.D., Ph.D., has been selected as a member of the Association of American Physicians. Harley, who chairs OMRF’s Arthritis and Immunology Research Program, was one of only 60 physicians nationwide chosen for membership this year. The 124-year-old Association selects members based on excellence in the pursuit of medical […]
OMRF finds new way to enhance cancer treatment
Scientists identify compound that boosts effects of Taxol, other drugs
Hiding in Plain Sight OMRF researchers discover rogue immune cells in healthy adults
A new study from OMRF has discovered that lurking in the bodies even of healthy people are numerous rogue immune cells, the cause of rheumatoid arthritis and a host of other diseases. The new findings could be key to developing new ways to prevent and treat autoimmune diseases, conditions like rheumatoid arthritis, lupus and type […]
American Association for the Advancement of Science selects OMRF scientist as Fellow
Oklahoma Medical Research Foundation scientist Jordan J.N. Tang, Ph.D., has been named a Fellow of the American Association for the Advancement of Science (AAAS). The announcement will appear in the December 19 edition of the journal Science. This year Tang is among 486 individuals honored nationally as a Fellow by AAAS because of their scientifically […]
OMRF seeking patients for arthritis and lupus studies, drug trials
Researchers at OMRF are looking for rheumatoid arthritis and lupus patients to take part in studies of new treatments for the diseases. OMRF’s Clinical Pharmacology Research Program conducts pharmaceutical studies on rheumatoid arthritis and lupus. “We are in a unique position here at OMRF in that we are able to conduct clinical trials that are […]
